Scopus BioPharma Inc.
0.00
null (null%)
At close: Jan 14, 2025, 8:00 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -0.18 -1.02 -17.14 -32.96 -129.24 n/a
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio -0.31 7.04 -108.29 -1.07K -16.65K n/a
P/FCF Ratio -0.25 -2.48 -78.53 -41.73 -118.63 n/a
P/OCF Ratio -0.25 -2.48 -78.53 -41.81 -118.63 n/a
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio n/a n/a -1.25 n/a n/a n/a
Quick Ratio 0.05 1.96 0.52 0.04 0.96 1.91
Current Ratio 0.05 1.96 0.52 0.90 0.96 1.91
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage n/a -35.67 -14.38 n/a n/a n/a
Return on Equity (ROE) 1.77 -6.9 6.32 32.46 128.80 n/a
Return on Assets (ROA) -29.6 -3.39 -5.86 -3.49 -5.17 n/a
Return on Capital (ROIC) 1.66 -6.88 5.55 32.46 128.80 n/a
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a